AI assistant
Aker BioMarine — Capital/Financing Update 2020
Dec 18, 2020
3527_rns_2020-12-18_62dfea7e-d89c-4da1-97b8-4c698e3f4cbb.html
Capital/Financing Update
Open in viewerOpens in your device viewer
Aker BioMarine is awarded a NOK 21.5 million grant from Innovation Norway for krill protein launch plant
Aker BioMarine is awarded a NOK 21.5 million grant from Innovation Norway for krill protein launch plant
Fornebu – 18th December 2020
Aker BioMarine receives a grant of NOK21.5 million from Innovation Norway to cover development activities on krill protein for human consumption at its planned launch plant in Norway. The launch plant requires an investment of around NOK 150 million and Innovation Norway will contribute NOK 21.5 million to cover operating costs for a period of three years.
The company will in Q1 2021 invite to a presentation of its work within the protein segment.
For further information, please contact Martin Stenshall, Investor Relations
Mobile: +47 47 33 83 31
Email: [email protected]
About Aker BioMarine
Aker BioMarine is a biotech innovator and Antarctic krill-harvesting company, dedicated to improving human and planetary health. The company develops krill-based ingredients for nutraceutical, aquaculture, and animal feed applications. The company’s fully transparent value chain stretches from sustainable krill harvesting in pristine Antarctic waters through its Montevideo logistics hub, Houston production plant, and all the way to customers around the world.